[1]
Gupta, V. and Gupta, J. 2024. Formulation and in-vitro anticancer activity of nilotinib immediate release and ibrutinib sustained release pellets. Journal of Applied Pharmaceutical Research. 12, 4 (Aug. 2024), 31-43. DOI:https://doi.org/10.69857/joapr.v12i4.571.